SARS-CoV-2 rS/Matrix M1-Adjuvant

Drug identity checked against registry records

Also recorded as NVX-CoV2373

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United KingdomNCT04583995NovavaxPhase 3Completed2022-03-29Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.